4 ms·
The US did not bank roll the R&D and manufacturing. The contracts were options to buy. No cash upfront. The companies, namely Moderna, got some public fundin
by refurb 5y ago
The US did not bank roll the R&D and manufacturing.
The contracts were options to buy. No cash upfront.
The companies, namely Moderna, got some public funding 10 years earlier. Pfizer did not. The rest was bankrolled by the companies themselves.
If the vaccines had failed they would have absorbed those loses entirely.
And I’ve seen the Pfizer contracts. Of course they were entirely indemnified - would you sell a government an “emergency approved” product and not protect yourself from getting sued into bankruptcy if something went wrong?
- 0xy 5y agoModerna, and most other manufacturers, received direct grant funding for both research and manufacturing through Operation Warp Speed via the CARES Act. I misspoke when I said Pfizer received that funding however, they only received an advance purchase agreement (which is not cash, but it does have a value even before maturation). Companies use advance purchase agreements as collateral for loans and other grant funding. It's also notable that Pfizer/BioNTech did receive grant money from other governments, up front.